Position:
Director, Translational Biology at GlaxoSmithKline
Location:
Greater Philadelphia Area
Work:
GlaxoSmithKline
since 2010
-
Director, Translational Biology
Synta Pharmaceuticals Corp. (Boston)
2007 - 2010
-
Director, In Vivo Pharmacology
Synta Pharmaceuticals Corp. (Boston)
2004 - 2007
-
Associate Director
Synta Pharmaceuticals Corp. (Boston)
2004 - 2004
-
Principal Scientist
Millennium Pharmaceuticals, Inc. (Boston)
2001 - 2003
-
Senior Scientist I / Group Leader
ZymoGenetics, Inc. (Seattle)
1998 - 2001
-
Scientist
Fred Hutchinson Cancer Research Center (Seattle)
1993 - 1998
-
Postdoctoral Fellow
Education:
Northwestern University 1987 - 1993
Ph.D., Biochemistry & Molecular Biology
Michigan State University 1982 - 1986
B.S., Biochemistry
Skills:
Immunology, Oncology, Animal Models, Cancer, Translational Medicine, Clinical Development, In Vivo, Drug Discovery, Autoimmunity, Biomarkers, Pharmacology, Diabetes, Translational Research, Biomarker Discovery, Cancer Research, Clinical Trials, Clinical Research, DMPK, Drug Development, Biotechnology
Honor & Awards:
Supernova award for contributions to $1B elesclomol partnership between Synta Pharmaceuticals & GlaxoSmithKline, 2007
American Cancer Society Postdoctoral Fellowship, 1994-1998
National Institutes of Health National Research Service Award, 1993
U.S. Army Research Office Predoctoral Fellowship, 1988-1989